| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $9.77M | $8.33M | $15.45M | $2.50M | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $120.27M | $99.79M | $87.89M | $164.95M | $173.27M |
| R&D | $86.40M | $66.00M | $56.78M | $91.17M | $131.94M |
| SG&A | $33.87M | $28.95M | $30.05M | $37.36M | $41.32M |
| Operating Income | -$110.50M | -$91.46M | -$72.44M | -$162.45M | -$173.27M |
| Interest Expense | – | – | $5.00M | $3.80M | $1.43M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$109.00M | -$89.30M | -$111.57M | -$166.01M | -$174.52M |
| EPS (basic) | -0.3400 | -0.3600 | -0.9600 | -3.7800 | -4.6400 |
| EPS (diluted) | -0.3400 | -0.3600 | -0.9600 | -3.7800 | -4.6400 |
| Shares (diluted) | $319.71M | $250.13M | $116.12M | $43.95M | $37.65M |